NerveTrace 800
Nerve imaging compatible with clinical ICG systems for Colorectal, Prostatectomy, Hysterectomy
Key Facts
About Trace Biosciences
Trace Biosciences is a clinical-stage biotech developing novel fluorescence imaging agents to visualize nerves intraoperatively, aiming to prevent the estimated 25 million nerve injuries that occur globally each year during surgery. The company's platform, built from a library of over 400 novel small-molecule fluorophores, has yielded its lead candidate, NerveTrace Dx, which has received FDA IND approval to begin clinical trials. With a seasoned leadership team and partnerships with top clinical institutions, Trace is positioned to address a significant unmet need in multiple surgical specialties, including orthopedic, reconstructive, and head & neck procedures.
View full company profile